GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Beneish M-Score

Haleon (Haleon) Beneish M-Score : -2.62 (As of May. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.62 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Haleon's Beneish M-Score or its related term are showing as below:

HLN' s Beneish M-Score Range Over the Past 10 Years
Min: -3.71   Med: -2.62   Max: -2.43
Current: -2.62

During the past 5 years, the highest Beneish M-Score of Haleon was -2.43. The lowest was -3.71. And the median was -2.62.


Haleon Beneish M-Score Historical Data

The historical data trend for Haleon's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Beneish M-Score Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - -2.43 -3.71 -2.62

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -2.62 -

Competitive Comparison of Haleon's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haleon's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Haleon's Beneish M-Score falls into.



Haleon Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Haleon for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9479+0.528 * 1.0147+0.404 * 0.9684+0.892 * 1.0817+0.115 * 0.9394
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9457+4.679 * -0.030862-0.327 * 0.956
=-2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $2,349 Mil.
Revenue was $14,306 Mil.
Gross Profit was $8,541 Mil.
Total Current Assets was $6,099 Mil.
Total Assets was $43,108 Mil.
Property, Plant and Equipment(Net PPE) was $2,408 Mil.
Depreciation, Depletion and Amortization(DDA) was $391 Mil.
Selling, General, & Admin. Expense(SGA) was $5,586 Mil.
Total Current Liabilities was $5,873 Mil.
Long-Term Debt & Capital Lease Obligation was $11,139 Mil.
Net Income was $1,328 Mil.
Gross Profit was $0 Mil.
Cash Flow from Operations was $2,658 Mil.
Total Receivables was $2,291 Mil.
Revenue was $13,225 Mil.
Gross Profit was $8,011 Mil.
Total Current Assets was $4,944 Mil.
Total Assets was $42,406 Mil.
Property, Plant and Equipment(Net PPE) was $2,313 Mil.
Depreciation, Depletion and Amortization(DDA) was $350 Mil.
Selling, General, & Admin. Expense(SGA) was $5,460 Mil.
Total Current Liabilities was $5,323 Mil.
Long-Term Debt & Capital Lease Obligation was $12,184 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2349.367 / 14306.329) / (2291.108 / 13225.335)
=0.164219 / 0.173236
=0.9479

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8010.962 / 13225.335) / (8540.506 / 14306.329)
=0.605728 / 0.596974
=1.0147

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (6098.734 + 2407.595) / 43107.595) / (1 - (4943.971 + 2313.033) / 42405.603)
=0.802672 / 0.828867
=0.9684

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=14306.329 / 13225.335
=1.0817

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(349.574 / (349.574 + 2313.033)) / (391.139 / (391.139 + 2407.595))
=0.13129 / 0.139756
=0.9394

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5586.076 / 14306.329) / (5460.414 / 13225.335)
=0.390462 / 0.412875
=0.9457

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((11139.241 + 5873.418) / 43107.595) / ((12183.922 + 5322.777) / 42405.603)
=0.394656 / 0.412839
=0.956

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1327.848 - 0 - 2658.228) / 43107.595
=-0.030862

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Haleon has a M-score of -2.59 suggests that the company is unlikely to be a manipulator.


Haleon (Haleon) Business Description

Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.